Characterisation of the roles of CD95 and CD95 ligand in cord blood

Bone Marrow Transplantation

Volumn 22, Issue SUPPL. 1, 1998, Pages

  Drenou B ^a   Choqueux, C ^a   El Ghalbzouri, A ^a   Blancheteau, V ^a   Toubert, A ^a   Charron, D ^a   Mooney, N ^a  

^a CENTRE DE RECHERCHE DES CORDELIERS   (France)

Author keywords

CD95; CD95L; Cord blood

Indexed keywords

CD95 LIGAND; FAS ANTIGEN; LIGAND; UNCLASSIFIED DRUG;

ANTIGEN EXPRESSION; APOPTOSIS; CELL DEATH; CELL POPULATION; CONFERENCE PAPER; CONTROLLED STUDY; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC CELL; HOMEOSTASIS; HUMAN; HUMAN CELL; MONONUCLEAR CELL; PHENOTYPE; PRIORITY JOURNAL; UMBILICAL CORD BLOOD;

ADULT; ANTIGENS, CD95; APOPTOSIS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FAS LIGAND PROTEIN; FETAL BLOOD; HUMANS; INFANT, NEWBORN; LIGANDS; MEMBRANE GLYCOPROTEINS; MONOCYTES;

EID: 0031927803     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (15)

1. Samali A, German AM, Cotter TG. Apoptosis - the story so far. Experientia 1996; 52: 933-941.
2. Rieux-Laucat F, Le Deist F, Hivroz C, IAG. Roberts. Mutations in Fas associated with human lymphoproliferative syndrome and autoimmunity. Science 1995; 268: 1347-1349.
3. Rothstein TL, Wang JKM, Panka DJ, Foote LC. Protection against Fas-dependent Th1-mediated apoptosis by antigen receptor engagement in B cells. Nature 1995; 374: 163-165.
4. Nagata S, Golstein P. The Fas death factor. Science (Washington DC) 1995; 267: 1449-1456.
5. Kischkel FC, Hellbardt S, Behrmann I, Germer M. Cytotoxicity-dependent APO-1 (Fas/CD95)-associated proteins form a death-inducing signaling complex (DISC) with the receptor. EMBO J 1995; 14: 5579-5588.
6. Peter ME, Kischkel FC, Hellbardt S, Chinnaiyan AM. CD95 (APO-1/Fas)-associating signalling proteins. Cell Death Differ 1996; 3: 161-170.
7. Cifone MG, De Maria R, Roncaioli P, Rippo MR. Apoptotic signaling through D95 (Fas/Apo-1) activates an acidic sphingomyelinase. J Exp Med 1993; 177: 1547-1552.
8. Watanabe-Fukunaga R, Brannan CI, Copeland NG, Jenkins NA. Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature 1992; 356: 314-317.
9. Takahashi T, Tanaka M, Brannan CI et al. Generalized lymphoproliferative disease in mice caused by a point mutation in the Fas ligand. Cell 1994; 76: 969-976.
10. Gluckmann E, Rocha V, Boyer-Chammard A, Locatelli F. Outcome of cord-blood transplantation from related and unrelated donors. New Engl J Med 1997; 337: 373-381.
11. Baker MB, Altman NH, Podack ER, Levy RB. The role of cell-mediated cytotoxicity in acute GVHD after MHC- matched allogeneic bone marrow transplantation in Mice. J Exp Med 1996; 183: 2645-2656.
12. Bellgrau D, Gold D, Selawry H, Moore J. A role for CD95 ligand in preventing graft rejection. Nature 1995; 377: 630- 632.
13. Yagita H, Seino K, Kayagaki N, Okumura K. CD95 ligand in graft rejection. Nature 1995; 379: 682.
14. Truman J-P, Choqueux C, Tschopp J, Vedrenne J. HLA class II-mediated death is induced via Fas/Fas ligand interactions in human splenic B lymphocytes. Blood 1997; 89: 1996-2007.
15. Badley A. McElhinney J, Leibson P, Lynch D. Upregulation of Fas Ligand expression by human immunodeficiency virus in human macrophages mediates apoptosis of uninfected T lymphocytes. J Virol 1996; 70: 199-206.